Towards a classification of biomarkers of neuropsychiatric disease: From encompass to compass

J. Davis, M. Maes, A. Andreazza, J. J. McGrath, Susannah J Tye, M. Berk

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

There is currently considerable imprecision in the nosology of biomarkers used in the study of neuropsychiatric disease. The neuropsychiatric field lags behind others such as oncology, wherein, rather than using 'biomarker' as a blanket term for a diverse range of clinical phenomena, biomarkers have been actively classified into separate categories, including prognostic and predictive tests. A similar taxonomy is proposed for neuropsychiatric diseases in which the core biology remains relatively unknown. This paper divides potential biomarkers into those of (1) risk, (2) diagnosis/trait, (3) state or acuity, (4) stage, (5) treatment response and (6) prognosis, and provides illustrative exemplars. Of course, biomarkers rely on available technology and, as we learn more about the neurobiological correlates of neuropsychiatric disorders, we will realize that the classification of biomarkers across these six categories can change, and some markers may fit into more than one category.

Original languageEnglish (US)
Pages (from-to)152-153
Number of pages2
JournalMolecular Psychiatry
Volume20
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Biomarkers
Technology

ASJC Scopus subject areas

  • Molecular Biology
  • Psychiatry and Mental health
  • Cellular and Molecular Neuroscience

Cite this

Davis, J., Maes, M., Andreazza, A., McGrath, J. J., Tye, S. J., & Berk, M. (2015). Towards a classification of biomarkers of neuropsychiatric disease: From encompass to compass. Molecular Psychiatry, 20(2), 152-153. https://doi.org/10.1038/mp.2014.139

Towards a classification of biomarkers of neuropsychiatric disease : From encompass to compass. / Davis, J.; Maes, M.; Andreazza, A.; McGrath, J. J.; Tye, Susannah J; Berk, M.

In: Molecular Psychiatry, Vol. 20, No. 2, 01.02.2015, p. 152-153.

Research output: Contribution to journalArticle

Davis, J, Maes, M, Andreazza, A, McGrath, JJ, Tye, SJ & Berk, M 2015, 'Towards a classification of biomarkers of neuropsychiatric disease: From encompass to compass', Molecular Psychiatry, vol. 20, no. 2, pp. 152-153. https://doi.org/10.1038/mp.2014.139
Davis, J. ; Maes, M. ; Andreazza, A. ; McGrath, J. J. ; Tye, Susannah J ; Berk, M. / Towards a classification of biomarkers of neuropsychiatric disease : From encompass to compass. In: Molecular Psychiatry. 2015 ; Vol. 20, No. 2. pp. 152-153.
@article{a6412be8006d4e66ab842c9c5803b228,
title = "Towards a classification of biomarkers of neuropsychiatric disease: From encompass to compass",
abstract = "There is currently considerable imprecision in the nosology of biomarkers used in the study of neuropsychiatric disease. The neuropsychiatric field lags behind others such as oncology, wherein, rather than using 'biomarker' as a blanket term for a diverse range of clinical phenomena, biomarkers have been actively classified into separate categories, including prognostic and predictive tests. A similar taxonomy is proposed for neuropsychiatric diseases in which the core biology remains relatively unknown. This paper divides potential biomarkers into those of (1) risk, (2) diagnosis/trait, (3) state or acuity, (4) stage, (5) treatment response and (6) prognosis, and provides illustrative exemplars. Of course, biomarkers rely on available technology and, as we learn more about the neurobiological correlates of neuropsychiatric disorders, we will realize that the classification of biomarkers across these six categories can change, and some markers may fit into more than one category.",
author = "J. Davis and M. Maes and A. Andreazza and McGrath, {J. J.} and Tye, {Susannah J} and M. Berk",
year = "2015",
month = "2",
day = "1",
doi = "10.1038/mp.2014.139",
language = "English (US)",
volume = "20",
pages = "152--153",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Towards a classification of biomarkers of neuropsychiatric disease

T2 - From encompass to compass

AU - Davis, J.

AU - Maes, M.

AU - Andreazza, A.

AU - McGrath, J. J.

AU - Tye, Susannah J

AU - Berk, M.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - There is currently considerable imprecision in the nosology of biomarkers used in the study of neuropsychiatric disease. The neuropsychiatric field lags behind others such as oncology, wherein, rather than using 'biomarker' as a blanket term for a diverse range of clinical phenomena, biomarkers have been actively classified into separate categories, including prognostic and predictive tests. A similar taxonomy is proposed for neuropsychiatric diseases in which the core biology remains relatively unknown. This paper divides potential biomarkers into those of (1) risk, (2) diagnosis/trait, (3) state or acuity, (4) stage, (5) treatment response and (6) prognosis, and provides illustrative exemplars. Of course, biomarkers rely on available technology and, as we learn more about the neurobiological correlates of neuropsychiatric disorders, we will realize that the classification of biomarkers across these six categories can change, and some markers may fit into more than one category.

AB - There is currently considerable imprecision in the nosology of biomarkers used in the study of neuropsychiatric disease. The neuropsychiatric field lags behind others such as oncology, wherein, rather than using 'biomarker' as a blanket term for a diverse range of clinical phenomena, biomarkers have been actively classified into separate categories, including prognostic and predictive tests. A similar taxonomy is proposed for neuropsychiatric diseases in which the core biology remains relatively unknown. This paper divides potential biomarkers into those of (1) risk, (2) diagnosis/trait, (3) state or acuity, (4) stage, (5) treatment response and (6) prognosis, and provides illustrative exemplars. Of course, biomarkers rely on available technology and, as we learn more about the neurobiological correlates of neuropsychiatric disorders, we will realize that the classification of biomarkers across these six categories can change, and some markers may fit into more than one category.

UR - http://www.scopus.com/inward/record.url?scp=84937717957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937717957&partnerID=8YFLogxK

U2 - 10.1038/mp.2014.139

DO - 10.1038/mp.2014.139

M3 - Article

C2 - 25349167

AN - SCOPUS:84937717957

VL - 20

SP - 152

EP - 153

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

IS - 2

ER -